Advanced search×

Comparing patient access to pharmaceuticals in the UK and US.

Appl Health Econ Health Policy 5(3):177-87 (2006) PMID 17132032

The debate on access to new drugs has focused on the time lag between applications for approval and granting of marketing authorisation. This delay was identified as the first barrier with respect to patient access to new drugs, encompassing the hurdles of safety, efficacy and quality. Additional barriers have since been identified. These pertain to reimbursement and pricing of approved drugs, the so-called fourth and fifth hurdles.

Version: za2963e q8za7 q8zb0 q8zc8 q8zd8 q8zed q8zf3 q8zge

Similar articles you may find interesting…

  1. High speed X-ray analysis of plant enzymes at room temperature

    Phytochemistry (2013) PMID 22704651

    X-ray measurements at room temperature (295K) deliver high quality data sets with unprecedented speed (<2min), as shown for crystallized raucaffricine-O-β-d-glucosidase (RG), its mutant RG-Glu186Gln and several ligand complexes of the enzyme which participates in alkaloid biosynthes...
  2. Optimal non-linear transformations for large scale structure statistics

    arXiv:1306.1230 [astro-ph.CO] 5 Jun 2013

    We show that at each order In perturbation theory, there is a polynomial of corresponding order exhausting The information on a given parameter. This polynomial can be interpreted as the Taylor expansion of the maximally efficient ``sufficient'' observable in the Non-linear regime. We determine expl...
  3. The investigation of early warning signs of aggression in forensic patients by means of the ‘Forensic Early Signs of Aggression Inventory’

    J Clin Nurs 22(11-12):1550-1558 (2013) PMID 23043702

    The FESAI categories with the highest frequency rank were the following: (1) anger, (2) social withdrawal, (3) superficial contact and (4) non-aggressive antisocial behaviour. There were no significant differences between subgroups of patients concerning the ranks of the four categories of early war...